100 results
Page 2 of 5
6-K
EX-99.4
zm4ietscnbqn
10 Aug 23
Current report (foreign)
8:28am
6-K
pzlic68adjjwrj0k
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.3
jx8trfvq76audb4xe0tc
10 Aug 23
Current report (foreign)
8:28am
6-K
6p0w2v3
14 Jul 23
Current report (foreign)
4:21pm
6-K
zmrmtruu
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
EX-99.1
7ewc1ldg41phknzn
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
0y3dhs
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.3
aewtswskph0os 18e
10 May 23
Current report (foreign)
7:27am
6-K
tk1nc4e2jgouas2q
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.1
5qjdjl9o56olxhno
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.1
a74xhcfp39apv
18 Apr 23
Current report (foreign)
4:13pm
6-K
syjw4s7ku6z1r5j8yn3
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
5zu0c00m7u0 hb
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
7j47v71g q0ugh8
2 Dec 22
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
5:08pm
6-K
EX-99.1
je6cctb 9dhhi40yjkhx
14 Nov 22
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
7:59am
6-K
p7v5ejecs2g rgvnq8qx
14 Nov 22
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
7:59am
6-K
tjh7i 6re
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.3
0ei7c7spshw77 7d7jb
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
o3rh51wda8bmsbsj385
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
6w9ms 0nm3ctxsbn1o4w
30 Sep 22
Prospectus with selling stockholder info
4:15pm